Zoetis Inc. (ZTS)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNYSEUnited StatesUS98978V1035
82.87 USD
-0.11% today Updated 13 Nov 2026 15:15
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Zoetis Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:15. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
11 Feb 2027
in 90 days · 08:00 · estimate 1.21
Last results
1.75 vs 1.51 estimated
05 Nov 2026 · Beat +15.8%
Beat the estimate
9 of 12
2 missed · 1 in line
Average surprise
+4.2%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Feb 2027 08:00 | 1.21 | — | — | Upcoming |
| 05 Nov 2026 07:00 | 1.51 | 1.75 | +15.8% | Beat |
| 06 Aug 2026 07:00 | 1.85 | 1.87 | +1.0% | In line |
| 07 May 2026 07:00 | 1.62 | 1.53 | -5.3% | Miss |
| 12 Feb 2026 07:00 | 1.40 | 1.48 | +5.5% | Beat |
| 04 Nov 2025 07:00 | 1.62 | 1.70 | +4.8% | Beat |
| 05 Aug 2025 07:00 | 1.61 | 1.76 | +9.2% | Beat |
| 06 May 2025 07:00 | 1.40 | 1.48 | +5.8% | Beat |
| 13 Feb 2025 07:00 | 1.36 | 1.40 | +2.8% | Beat |
| 04 Nov 2024 07:00 | 1.46 | 1.58 | +8.0% | Beat |
| 06 Aug 2024 07:00 | 1.48 | 1.56 | +5.3% | Beat |
| 02 May 2024 07:00 | 1.34 | 1.38 | +3.2% | Beat |
| 13 Feb 2024 07:00 | 1.32 | 1.24 | -5.9% | Miss |
| 02 Nov 2023 07:00 | 1.36 | 1.36 | +0.4% | In line |
| 08 Aug 2023 07:00 | 1.31 | 1.41 | +8.0% | Beat |
| 04 May 2023 07:00 | 1.25 | 1.31 | +4.5% | Beat |
| 14 Feb 2023 07:00 | 1.15 | 1.15 | +0.3% | In line |
| 03 Nov 2022 07:00 | 1.24 | 1.21 | -2.1% | Miss |
| 04 Aug 2022 07:00 | 1.22 | 1.20 | -1.6% | Miss |
| 05 May 2022 07:00 | 1.22 | 1.32 | +8.0% | Beat |
| 15 Feb 2022 07:00 | 0.96 | 1.00 | +3.8% | Beat |
| 04 Nov 2021 07:00 | 1.11 | 1.25 | +12.5% | Beat |
| 05 Aug 2021 07:00 | 1.09 | 1.19 | +9.3% | Beat |
| 06 May 2021 07:00 | 1.04 | 1.26 | +21.6% | Beat |
| 16 Feb 2021 07:00 | 0.87 | 0.91 | +4.8% | Beat |
| 05 Nov 2020 07:00 | 0.92 | 1.10 | +20.2% | Beat |
| 06 Aug 2020 07:00 | 0.65 | 0.89 | +37.1% | Beat |
| 06 May 2020 08:00 | 0.87 | 0.95 | +9.3% | Beat |
| 13 Feb 2020 07:00 | 0.88 | 0.92 | +4.3% | Beat |
| 07 Nov 2019 07:00 | 0.89 | 0.94 | +6.2% | Beat |
| 06 Aug 2019 07:00 | 0.82 | 0.90 | +9.4% | Beat |
| 02 May 2019 07:00 | 0.79 | 0.88 | +11.6% | Beat |
| 14 Feb 2019 07:00 | 0.77 | 0.79 | +2.4% | Beat |
| 01 Nov 2018 07:00 | 0.77 | 0.83 | +7.4% | Beat |
| 02 Aug 2018 07:00 | 0.70 | 0.77 | +9.5% | Beat |
| 02 May 2018 07:00 | 0.69 | 0.75 | +8.1% | Beat |
| 15 Feb 2018 07:00 | 0.66 | 0.69 | +4.7% | Beat |
| 02 Nov 2017 07:00 | 0.62 | 0.65 | +4.0% | Beat |
| 08 Aug 2017 07:00 | 0.53 | 0.53 | +0.5% | In line |
| 04 May 2017 07:00 | 0.48 | 0.53 | +11.0% | Beat |
| 16 Feb 2017 07:00 | 0.45 | 0.47 | +3.8% | Beat |
| 02 Nov 2016 07:00 | 0.46 | 0.52 | +12.4% | Beat |
| 03 Aug 2016 07:00 | 0.44 | 0.49 | +10.6% | Beat |
| 04 May 2016 07:00 | 0.41 | 0.48 | +16.8% | Beat |
| 16 Feb 2016 07:00 | 0.39 | 0.43 | +11.2% | Beat |
| 03 Nov 2015 07:00 | 0.40 | 0.50 | +25.5% | Beat |
| 04 Aug 2015 07:00 | 0.38 | 0.43 | +13.2% | Beat |
| 05 May 2015 07:00 | 0.37 | 0.41 | +12.2% | Beat |
| 11 Feb 2015 07:00 | 0.36 | 0.40 | +12.4% | Beat |
| 04 Nov 2014 07:00 | 0.37 | 0.41 | +10.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 9.5B | +2.3% | 2.7B | 28.2% | 6.02 | +10.1% | 2.3B |
| 2024 | 9.3B | +8.3% | 2.5B | 26.9% | 5.47 | +7.9% | 2.3B |
| 2023 | 8.5B | +5.7% | 2.3B | 27.4% | 5.07 | +12.9% | 1.6B |
| 2022 | 8.1B | — | 2.1B | 26.2% | 4.49 | — | 1.3B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 80.45 | 83.84 | 79.59 | 82.87 | +4.37% | 20,162,186 | |
| 02 Nov 2026 – 06 Nov 2026 | 80.15 | 89.29 | 78.63 | 79.40 | -0.40% | 34,423,000 | |
| 26 Oct 2026 – 30 Oct 2026 | 80.95 | 81.19 | 77.03 | 79.72 | -1.62% | 15,408,400 | 0.5300 |
| 19 Oct 2026 – 23 Oct 2026 | 78.85 | 82.29 | 78.45 | 81.03 | +2.08% | 17,530,500 | |
| 12 Oct 2026 – 16 Oct 2026 | 75.00 | 80.59 | 74.17 | 79.38 | +6.11% | 22,132,200 | |
| 05 Oct 2026 – 09 Oct 2026 | 69.41 | 74.85 | 69.00 | 74.81 | +7.35% | 20,295,200 | |
| 28 Sep 2026 – 02 Oct 2026 | 70.50 | 71.70 | 68.77 | 69.69 | -1.91% | 22,478,500 | |
| 21 Sep 2026 – 25 Sep 2026 | 72.06 | 73.55 | 69.52 | 71.05 | -0.49% | 19,146,400 | |
| 14 Sep 2026 – 18 Sep 2026 | 74.20 | 74.82 | 71.40 | 71.40 | -2.15% | 26,354,300 | |
| 08 Sep 2026 – 11 Sep 2026 | 74.80 | 75.10 | 71.50 | 72.97 | -3.75% | 21,751,000 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Zoetis' Cytopoint Plus Gets USDA License for 75-Day Canine Itch Relief (opens in a new tab) Zacks · 12 Nov 2026 13:48
- Zoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic Dermatitis (opens in a new tab) 11 Nov 2026 12:30
- What Are Wall Street Analysts' Target Price for Zoetis Stock? (opens in a new tab) Barchart · 11 Nov 2026 10:52
- Should You Buy Zoetis Stock At This Price? (opens in a new tab) Trefis · 11 Nov 2026 00:27
- Zoetis to Participate in the Jefferies Global Healthcare Conference in London (opens in a new tab) 10 Nov 2026 12:30
- ZTS Q3 2026 deep dive: competitive pressures and margin headwinds weigh on outlook (opens in a new tab) StockStory · 10 Nov 2026 09:41
- ZTS Q3 Earnings Call Highlights Competitive Pressures and Outlook (opens in a new tab) Zacks · 09 Nov 2026 14:00
- What Zoetis (ZTS) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 08 Nov 2026 22:14
- Zoetis (ZTS) Stock Price Drops After Q3 Earnings Margin Pressure (opens in a new tab) Simply Wall St. · 06 Nov 2026 23:10
- Zoetis: Quality Company Trading Cheap (opens in a new tab) SeekingAlpha · 06 Nov 2026 09:18
- Zoetis Inc. (ZTS) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 06 Nov 2026 05:24
- Zoetis: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 06 Nov 2026 03:07
- Zoetis Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 06 Nov 2026 02:30
- Zoetis (ZTS) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 21:35
- No Greyhounds Here: Pet-Health Giant Zoetis Reverses 30% Monthlong Sprint (opens in a new tab) Investor's Business Daily · 05 Nov 2026 21:27
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 82.96 USD
- Market cap
- 33.7B
- Dividend yield
- 2.56%
- 5-year average yield
- 0.94%
- Payout ratio
- 35%
- Last dividend
- 0.5300 USD · 30 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 30 Oct 2026 | 0.5300 USD |
| 20 Jul 2026 | 0.5300 USD |
| 20 Apr 2026 | 0.5300 USD |
| 20 Jan 2026 | 0.5300 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow ZTS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.